China · Delayed Price · Currency is CNY Bright Eye Hospital Group Statistics
Total Valuation
SHE:301239 has a market cap or net worth of CNY 4.56 billion. The enterprise value is 6.10 billion.
| Market Cap | 4.56B |
| Enterprise Value | 6.10B |
Important Dates
The last earnings date was Saturday, August 29, 2026.
| Earnings Date | Aug 29, 2026 |
| Ex-Dividend Date | Sep 11, 2026 |
Share Statistics
SHE:301239 has 148.86 million shares outstanding. The number of shares has increased by 0.97% in one year.
| Current Share Class | 148.86M |
| Shares Outstanding | 148.86M |
| Shares Change (YoY) | +0.97% |
| Shares Change (QoQ) | -1.29% |
| Owned by Insiders (%) | 42.88% |
| Owned by Institutions (%) | 20.81% |
| Float | 77.85M |
Valuation Ratios
The trailing PE ratio is 364.59.
| PE Ratio | 364.59 |
| Forward PE | n/a |
| PS Ratio | 1.55 |
| PB Ratio | 2.11 |
| P/TBV Ratio | 3.00 |
| P/FCF Ratio | 12.17 |
| P/OCF Ratio | 7.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.87, with an EV/FCF ratio of 16.27.
| EV / Earnings | 487.23 |
| EV / Sales | 2.07 |
| EV / EBITDA | 11.87 |
| EV / EBIT | 29.98 |
| EV / FCF | 16.27 |
Financial Position
The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.94.
| Current Ratio | 0.99 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | 3.95 |
| Debt / FCF | 5.42 |
| Interest Coverage | 10.53 |
Financial Efficiency
Return on equity (ROE) is 0.97% and return on invested capital (ROIC) is 1.41%.
| Return on Equity (ROE) | 0.97% |
| Return on Assets (ROA) | 2.71% |
| Return on Invested Capital (ROIC) | 1.41% |
| Return on Capital Employed (ROCE) | 5.42% |
| Weighted Average Cost of Capital (WACC) | 5.47% |
| Revenue Per Employee | 585,898 |
| Profits Per Employee | 2,495 |
| Employee Count | 5,018 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 8.06 |
Taxes
In the past 12 months, SHE:301239 has paid 61.75 million in taxes.
| Income Tax | 61.75M |
| Effective Tax Rate | 74.79% |
Stock Price Statistics
The stock price has decreased by -20.47% in the last 52 weeks. The beta is 0.65, so SHE:301239's price volatility has been lower than the market average.
| Beta (5Y) | 0.65 |
| 52-Week Price Change | -20.47% |
| 50-Day Moving Average | 33.13 |
| 200-Day Moving Average | 34.70 |
| Relative Strength Index (RSI) | 36.67 |
| Average Volume (20 Days) | 2,272,424 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301239 had revenue of CNY 2.94 billion and earned 12.52 million in profits. Earnings per share was 0.08.
| Revenue | 2.94B |
| Gross Profit | 1.22B |
| Operating Income | 203.44M |
| Pretax Income | 82.57M |
| Net Income | 12.52M |
| EBITDA | 350.72M |
| EBIT | 203.44M |
| Earnings Per Share (EPS) | 0.08 |
Balance Sheet
The company has 533.51 million in cash and 2.03 billion in debt, with a net cash position of -1.50 billion or -10.06 per share.
| Cash & Cash Equivalents | 533.51M |
| Total Debt | 2.03B |
| Net Cash | -1.50B |
| Net Cash Per Share | -10.06 |
| Equity (Book Value) | 2.17B |
| Book Value Per Share | 14.36 |
| Working Capital | -6.96M |
Cash Flow
In the last 12 months, operating cash flow was 632.49 million and capital expenditures -257.55 million, giving a free cash flow of 374.93 million.
| Operating Cash Flow | 632.49M |
| Capital Expenditures | -257.55M |
| Depreciation & Amortization | 147.28M |
| Net Borrowing | -142.54M |
| Free Cash Flow | 374.93M |
| FCF Per Share | 2.52 |
Margins
Gross margin is 41.60%, with operating and profit margins of 6.92% and 0.43%.
| Gross Margin | 41.60% |
| Operating Margin | 6.92% |
| Pretax Margin | 2.81% |
| Profit Margin | 0.43% |
| EBITDA Margin | 11.93% |
| EBIT Margin | 6.92% |
| FCF Margin | 12.75% |
Dividends & Yields
This stock pays an annual dividend of 0.60, which amounts to a dividend yield of 1.78%.
| Dividend Per Share | 0.60 |
| Dividend Yield | 1.78% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 150.08% |
| Buyback Yield | -0.97% |
| Shareholder Yield | 0.81% |
| Earnings Yield | 0.27% |
| FCF Yield | 8.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |